<DOC>
	<DOCNO>NCT00892320</DOCNO>
	<brief_summary>The purpose study evaluate effect food pharmacokinetics extended-release ( ER ) OROS paliperidone healthy Japanese adult assess safety tolerability .</brief_summary>
	<brief_title>A Study Effect Food Pharmacokinetics ER OROS Paliperidone Healthy Japanese Volunteers</brief_title>
	<detailed_description>This study design randomize , open-label , single-center , crossover study evaluate effect food pharmacokinetics extended-release ( ER ) OROS paliperidone healthy Japanese adult . Of 20 Japanese volunteer enrol , least 6 men 6 woman . All volunteer receive single dos 3 mg ER OROS paliperidone without standard Japanese breakfast . There 1-week washout treatment , total treatment duration approximately 2 week . Volunteers randomly assign 1 2 treatment sequence group ( feed fast ; fast fed ) . The pharmacokinetics paliperidone assess 96 hour dose . Safety tolerability monitor throughout study . Prior initiate clinical trial Japan , food effect study require evaluate effect food pharmacokinetics ER OROS paliperidone Japanese adult . 3 mg tablet , single oral dose , fast feed condition</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Paliperidone Palmitate</mesh_term>
	<criteria>Japanese volunteer must bear Japan Japanese parent live outside Japan 5 year Female volunteer must surgically sterile , practice effective method birth control ( e.g. , prescription oral contraceptive , contraceptive injection , intrauterine device , doublebarrier method , contraceptive patch , male partner sterilization ) entry throughout study , negative serum betaHCG pregnancy test screen negative urine pregnancy test Day 1 Volunteers must sign informed consent document indicate understand purpose procedure require study willing participate study Volunteers must sign informed consent document pharmacogenomic testing However , participation genetic test component mandatory participation remainder study Volunteers must weight define Body Mass Index Quetelet Index ( weight [ kg ] /height ( ) Â² ) within range 18.0 25.0 , extreme include must normotensive supine ( 5 min ) blood pressure range 100139 mm Hg systolic 6089 mm Hg diastolic Volunteers must healthy basis prestudy physical examination , medical history , electrocardiogram , result blood biochemistry hematology test urinalysis carry less 3 week first dose . If result biochemistry hematology test urinalysis test within laboratory 's reference range volunteer include condition investigator judge deviation clinically significant . For liver function test ( AST , ALT , bilirubin ) value must within 2 time upper limit normal reference range Volunteers must smoke less 10 cigarette per day agree change smoke habit study Relevant history significant and/or unstable cardiovascular , respiratory , neurologic ( include seizure significant cerebrovascular ) , renal , hepatic , endocrine , psychiatric , immunologic disorder History severe preexist gastrointestinal narrowing ( pathologic iatrogenic ) Inability swallow study medication ( volunteer may chew , divide , dissolve , crush study medication ) History suspicion alcohol , barbiturate , amphetamine narcotic abuse Drug allergy risperidone , paliperidone excipients Use concomitant medication ( include vitamin herbal supplement ) , except paracetamol ( acetaminophen ) hormonal contraceptive . All medication must stop least 14 day first dose study At screening , 2 3 minute stand , experience decrease great equal 20 mmHg systolic blood pressure , decrease great equal 10 mmHg diastolic blood pressure , increase great equal 20 beat per minute heart rate symptom lightheadedness , dizziness , faint upon stand supine position Positive serology test hepatitis B , C HIV Female volunteer pregnant , nursing , plan become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Schizophrenia , mood stabilizer , antipsychotic</keyword>
	<keyword>ER OROS paliperidone</keyword>
</DOC>